Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity. Holgate RGE, Weldon R, Jones TD, Baker MP PLoS One. 2015; 10(9):e0138123. Epub 2015 Sep 15. PMID: 26372145. Abstract CommentRecommendBookmarkWatch